Back
Corcept Therapeutics Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
CORT
Corcept Therapeutics
Last Price:
$70.59
Seasonality Move:
6.42%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.72 | Sell |
| 20-day SMA: | 65.73 | Buy |
| 50-day SMA: | 64.92 | Buy |
| 200-day SMA: | 49.1 | Buy |
| 8-day EMA: | 74.01 | Buy |
| 20-day EMA: | 53.91 | Buy |
| 50-day EMA: | 29.29 | Buy |
| 200-day EMA: | 8.68 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.64 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | 841196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.33 - 78.25) | Buy |
| Bollinger Bands (100): | (50.74 - 69.42) | Buy |
Corcept Therapeutics Technical Analysis
| Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 74.65 while CORT 8-day simple moving average is 78.72, which is a Sell signal.
-
The stock price of CORT is 74.65 while Corcept Therapeutics 20-day SMA is 65.73, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 64.92 while CORT share price is 74.65, making it a Buy technically.
-
CORT stock price is 74.65 and Corcept Therapeutics 200-day simple moving average is 49.10, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
52
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $74.65. The Score for CORT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
8B
Price in USD:
74.65
Share Volume:
2.6M
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
20.84
Buy
52
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 74.65 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 74.65 while CORT 8-day exponential moving average is 74.01, which is a Buy signal.
-
The stock price of CORT is 74.65 while Corcept Therapeutics 20-day EMA is 53.91, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 29.29 while CORT share price is 74.65, making it a Buy technically.
-
CORT stock price is 74.65 and Corcept Therapeutics 200-day simple moving average is 8.68, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 20.64, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 54.3, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (49.33 - 78.25), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (50.74 - 69.42), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.